New Zealand markets closed

Novartis AG (NVS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
84.54-0.59 (-0.69%)
At close: 04:00PM EST
83.09 -1.45 (-1.72%)
After hours: 07:55PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 180.78B
Enterprise value 206.95B
Trailing P/E 18.63
Forward P/E 12.17
PEG ratio (5-yr expected) 2.11
Price/sales (ttm)3.49
Price/book (mrq)3.18
Enterprise value/revenue 3.95
Enterprise value/EBITDA 11.03

Trading information

Stock price history

Beta (5Y monthly) 0.56
52-week change 3-8.36%
S&P500 52-week change 317.58%
52-week high 395.17
52-week low 379.34
50-day moving average 384.67
200-day moving average 387.46

Share statistics

Avg vol (3-month) 32.49M
Avg vol (10-day) 32.36M
Shares outstanding 52.24B
Implied shares outstanding 6N/A
Float 82.15B
% held by insiders 10.01%
% held by institutions 19.96%
Shares short (30 Dec 2021) 47.38M
Short ratio (30 Dec 2021) 42.69
Short % of float (30 Dec 2021) 4N/A
Short % of shares outstanding (30 Dec 2021) 40.33%
Shares short (prior month 29 Nov 2021) 46.68M

Dividends & splits

Forward annual dividend rate 43.2
Forward annual dividend yield 43.78%
Trailing annual dividend rate 33.40
Trailing annual dividend yield 33.99%
5-year average dividend yield 43.45
Payout ratio 473.88%
Dividend date 314 Mar 2021
Ex-dividend date 403 Mar 2021
Last split factor 21116:1000
Last split date 308 Apr 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021


Profit margin 18.72%
Operating margin (ttm)27.94%

Management effectiveness

Return on assets (ttm)7.29%
Return on equity (ttm)17.60%

Income statement

Revenue (ttm)52.39B
Revenue per share (ttm)23.30
Quarterly revenue growth (yoy)6.60%
Gross profit (ttm)35.5B
Net income avi to common (ttm)9.81B
Diluted EPS (ttm)4.33
Quarterly earnings growth (yoy)42.50%

Balance sheet

Total cash (mrq)8.11B
Total cash per share (mrq)3.62
Total debt (mrq)34.33B
Total debt/equity (mrq)60.29
Current ratio (mrq)0.88
Book value per share (mrq)25.38

Cash flow statement

Operating cash flow (ttm)15.19B
Levered free cash flow (ttm)11.8B